This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Neurology
Neurology
Phase III trials of Fycompa®
Parkinson’s disease and medicines management
EC approved perampanel for partial-onset epilepsy
Positive Phase III perampanel data released
Swissmedic approves oral Inovelon for some seizures
Zonegran children extension submitted to EMA
Gilenya safety and efficacy ‘consistent for 4.5 years’
Lundbeck Alzheimer’s drug meets primary endpoint
First-in-class epilepsy product gains CHMP approval
CHMP issues positive opinion of zonisamide
Excellence in Epilepsy Journalism winners announced
UCB announces World Parkinson’s Disease Day initiative
« Previous
1
…
9
10
11
12
13
…
36
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: